Inventor · disambiguated record
Yibin Xiang
Also filed as: XIANG YIBIN
22 granted patents·15 pending applications·493 citations·filing 1993–2024
95Inventor score
Top patents by PatentIndex Score
37 records- 0197US6828344B1Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2000·Granted Dec 7, 2004·109 cites·16 claims
- 0297US6630496B1Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2000·Granted Oct 7, 2003·145 cites·18 claims
- 0397US6500853B1Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2000·Granted Dec 31, 2002·104 cites·19 claims
- 0494US6916841B2Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2002·Granted Jul 12, 2005·45 cites·28 claims
- 0592US11008316B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2017·Granted May 18, 2021·6 cites·2 claims
- 0690US8304447B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2008·Granted Nov 6, 2012·18 cites·20 claims
- 0788US8309593B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2009·Granted Nov 13, 2012·15 cites·15 claims
- 0887US8940776B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2012·Granted Jan 27, 2015·11 cites·19 claims
- 0986US12060349B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Granted Aug 13, 2024·1 cites·7 claims
- 1082US9272996B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2012·Granted Mar 1, 2016·6 cites·16 claims
- 1182US2025026749A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2024·Application pending·0 cites
- 1279US9745294B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Granted Aug 29, 2017·3 cites·24 claims
- 1378US7462594B2Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteasesTAIGEN BIOTECHNOLOGY CO LTD·Filed 2005·Granted Dec 9, 2008·2 cites·2 claims
- 1478US7183413B2Aminoquinoline compoundsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2004·Granted Feb 27, 2007·18 cites·46 claims
- 1572US9744153B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2016·Granted Aug 29, 2017·1 cites·14 claims
- 1672US2021261557A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Application pending·0 cites
- 1766US8633168B2Inhibitors of S-adenosyl-L-methionine decarboxylaseXIANG YIBIN·Filed 2008·Granted Jan 21, 2014·1 cites·18 claims
- 1864US7399776B2Polyamine compounds for treating chemokine receptor mediated diseasesTAIGEN BIOTECHNOLOGY CO LTD·Filed 2004·Granted Jul 15, 2008·3 cites·6 claims
- 1964US2020048266A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2019·Application pending·0 cites
- 2061US2024423952A1Compositions and methods for treating congenital disordersIBAGEN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2157US2015210681A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2013·Application pending·0 cites
- 2257US2018093981A12-Acylaminopropoanol-Type Glucosylceramide Synthase InhibitorsGENZYME CORP·Filed 2017·Application pending·0 cites
- 2356US7378524B2Aminoquinoline compoundsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2004·Granted May 27, 2008·1 cites·11 claims
- 2453US2016207933A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2015·Application pending·0 cites
- 2550US2008125375A1Protease inhibitorsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2007·Application pending·0 cites
- 2649US7304088B2Protease inhibitorsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2004·Granted Dec 4, 2007·0 cites·15 claims
- 2748US2017137426A1Heterocyclic compounds as axl inhibitorsCHANGZHOU JIEKAI PHARMATECH CO LTD·Filed 2014·Application pending·0 cites
- 2846US7501526B2Synthesis of polyamine compoundsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2005·Granted Mar 10, 2009·0 cites·19 claims
- 2944US2006273819A1Antibiotic tetrahydro-beta-carboline derivativesOPPERMAN TIMOTHY·Filed 2004·Application pending·0 cites
- 3042US2006287351A1Antibiotic cycloalkyltetrahydroquinoline derivativesLABAUDINIERE RICHARD F·Filed 2004·Application pending·0 cites
- 3142US2011275673A1Inhibitors of sphingosine kinase 1XIANG YIBIN·Filed 2009·Application pending·0 cites
- 3241US2018312525A1NAMPT Inhibitors for Cancer TherapyGENZYME CORP·Filed 2018·Application pending·0 cites
- 3340US5350760AAza-5,5-fused hetrocyclic acids as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1993·Granted Sep 27, 1994·4 cites·14 claims
- 3440US2006036093A1Pyrimidinone compoundsTAIGEN BIOTECHNOLOGY CO LTD·Filed 2005·Application pending·0 cites
- 3539US2007027190A1Antibacterial fab i inhibitorsMOIR DONALD T·Filed 2004·Application pending·0 cites
- 3638US10017523B2NAMPT inhibitors and methodsGENZYME CORP·Filed 2015·Granted Jul 10, 2018·0 cites·38 claims
- 3732US8980926B22-aminoindole compounds and methods for the treatment of malariaMAZITSCHEK RALPH·Filed 2010·Granted Mar 17, 2015·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Yibin Xiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →